BioArctic Denmark ApS: Financial statements 2024
CVR: 43775154
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioArctic Denmark ApS (CVR 43775154) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,230,465 and a net result of DKK 236,864 compared with DKK 183,915 the year before. That is an increase of 1.7% compared with the year before. Equity in the 2024 report amounted to DKK 841,639. The solvency ratio was 65.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,230,465
- Profit/Loss
- DKK 236,864
- Equity
- DKK 841,639
- Total Assets
- DKK 1,291,868
- Employees
- 2
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioArctic Denmark ApS has published its annual report for 2023. Gross profit came to DKK 3,177,364, and the net result was DKK 183,915.
As of June 27, 2024, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of BioArctic Denmark ApS.
About BioArctic Denmark ApS
BioArctic Denmark ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anna-Kaija Grönblad. The board consists of Gunilla Christina Osswald (chair), Anders Jussi Martin-Löf and Emilie Hélène Ankarcrona Smith. The company is owned by BioArctic AB. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,908,090 and a net result of DKK 284,133 compared with DKK 236,864 the year before. Equity in the 2025 report amounted to DKK 1,344,874.